- Home
- App Analytics
- RAJo
- RAJo Vs. Rheumatoid Arthritis [RA]
RAJo vs Rheumatoid Arthritis [RA] Usage & Stats
A Jordanian Society of Rheumatology App for the use of patients to monitor their disease activities
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Rheumatologic Diseases @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI , clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI , confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Rheumatologic Diseases @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Rheumatoid Arthritis content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
- Apple App Store
- Free
- Medical
Store Rank
- -
RAJo vs. Rheumatoid Arthritis [RA] ranking comparison
Compare RAJo ranking trend in the past 28 days vs. Rheumatoid Arthritis [RA]
Rank
No Data Available
RAJo vs. Rheumatoid Arthritis [RA] ranking by country comparison
Compare RAJo ranking trend in the past 28 days vs. Rheumatoid Arthritis [RA]
No Data to Display
Compare to any site with our free trial
RAJo VS.
Rheumatoid Arthritis [RA]
December 15, 2024